Speaker: 

Matt Oetjens, PhD, Assistant Professor, Autism & Developmental Medicine Institute, Geisinger - has nothing to disclose.

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• report on the prevalence of four sex chromosome aneuploidies (47,XXY, 47,XXX, 47, XYY, and 45,X) in different population settings
• demonstrate the risk of venous thromboembolism and autism among individuals with sex chromosome aneuploidies
• examine Geisinger’s efforts in returning genetic information about sex chromosome aneuploidies to patients

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Christa Martin, PhD, Eric Wright, PharmD, MPH, Adam Buchanan, MS, MPH, CGC, Candice Laubach, MBA, Jenn Nunamaker and Christian Lynch, MPH have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPPA compliant. 

Commercial Support for this Session

None.